Synthesis and biological activity of galanthamine derivatives as acetylcholinesterase (AChE) inhibitors

Bioorganic & Medicinal Chemistry Letters
1991.0

Abstract

The syntheses of several ester and carbamate derivatives of galanthamine are described. These compounds are potential therapeutic agents in the treatment of Alzheimer's disease (AD). The inhibition of cortical acetylcholinesterase (AChE) by these drug candidates with different side chains was investigated. Side chain length as well as branching affected the AChE inhibitory activity. Esters were generally less effective than carbamates.

Knowledge Graph

Similar Paper

Synthesis and biological activity of galanthamine derivatives as acetylcholinesterase (AChE) inhibitors
Bioorganic & Medicinal Chemistry Letters 1991.0
Design, synthesis and evaluation of galanthamine derivatives as acetylcholinesterase inhibitors
European Journal of Medicinal Chemistry 2009.0
Potent acetylcholinesterase inhibitors: design, synthesis and structure–activity relationships of alkylene linked bis-galanthamine and galanthamine–galanthaminium salts
Bioorganic & Medicinal Chemistry Letters 2000.0
Acetylcholinesterase Inhibitors:  Synthesis and Structure−Activity Relationships of ω-[N-Methyl-N-(3-alkylcarbamoyloxyphenyl)- methyl]aminoalkoxyheteroaryl Derivatives
Journal of Medicinal Chemistry 1998.0
Design, synthesis and evaluation of flavonoid derivatives as potential multifunctional acetylcholinesterase inhibitors against Alzheimer’s disease
Bioorganic & Medicinal Chemistry Letters 2013.0
Galantamine derivatives with indole moiety: Docking, design, synthesis and acetylcholinesterase inhibitory activity
Bioorganic & Medicinal Chemistry 2015.0
Cholinesterase Inhibitors:  Xanthostigmine Derivatives Blocking the Acetylcholinesterase-Induced β-Amyloid Aggregation
Journal of Medicinal Chemistry 2005.0
6-Hydroxy- and 6-methoxy-β-carbolines as acetyl- and butyrylcholinesterase inhibitors
Bioorganic & Medicinal Chemistry Letters 2006.0
Synthesis, anticholinesterase activity and structure–Activity relationships of m-Aminobenzoic acid derivatives
Bioorganic & Medicinal Chemistry Letters 2003.0
Derivatives of montanine-type alkaloids and their implication for the treatment of Alzheimer's disease: Synthesis, biological activity and in silico study
Bioorganic & Medicinal Chemistry Letters 2021.0